Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000438447

Medchemexpress LLC 9-ING-41 | 1034895-42-5 | 99.13% | 404.35 | 100 MG
SDP

Supplier:  Medchemexpress LLC HY113914100MG

Encompass_Preferred

9-ING-41 (Elraglusib) is a maleimide-based ATP-competitive and selective glycogen synthase kinase-3β (GSK-3β) inhibitor with an IC50 of 0.71 μM. This compound significantly induces cell cycle arrest, autophagy, and apoptosis in cancer cells. It demonstrates anticancer activity and shows potential for enhancing the antitumor effects of chemotherapeutic agents.

  • It is a maleimide-based ATP-competitive and selective glycogen synthase kinase-3β (GSK-3β) inhibitor.
  • It leads to cell cycle arrest, autophagy, and apoptosis in cancer cells.
  • It has anticancer activity.
  • It has the potential for enhancing the antitumor effects of chemotherapeutic agents.

Catalog No. 50-004-38447


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.